Sort   by:  
 Page size 
ProteomicsFrom Cell Lines To The Clinic: Identifying A Specific Urinary BlCa-EV Signature In Comparative Proteomics Of Bladder Cancer Lysates And Extracellular Vesicles
Background: There is an urgent need for the development of innovative diagnostic and therapeutic strategies in bladder cancer (BlCa) management, due to its significant incidence, mortality and morbidity. Extracellular vesicles (EVs) represent highly promising candidates as biomarkers, as their cargo...
ORGANISM(S): Homo sapiens (Human) 
2026-06-08 | PXD071837 | Pride
Bladder cancer Proteomics Cell lines Urine Extracellular vesicles 
ProteomicsProteomic Profiling Of Bladder Cancer Patients-Derived Extracellular Vesicles
Extracellular vesicle (EV) proteomics holds great promise for non-invasive cancer biomarker discovery. This study presents the first comprehensive proteomic characterization of EVs from tissue, plasma, and urine, focusing on bladder cancer BlCa. EVs were isolated via ultracentrifugation, and their c...
ORGANISM(S): Homo sapiens (Human) 
2026-06-08 | PXD062618 | Pride
Extracellular vesicles  proteomics  liquid biopsy  biomarker  bladder cancer 
UnknownLiver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism.
Not available
S-EPMC8501936 | biostudies-literature
UnknownComparison of seven prognostic tools to identify low-risk pulmonary embolism in patients aged <50 years.
Not available
S-EPMC6934558 | biostudies-literature
UnknownValidation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry.
Not available
S-EPMC9862219 | biostudies-literature
UnknownImpact of SARS-CoV-2 infection therapies on the risk of venous thromboembolism and cardiovascular events from the SEMI-COVID-19 Registry.
Not available
S-EPMC11882944 | biostudies-literature
Sort   by:  
 Page size